Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hodgkin Disease × tislelizumab × Clear all

Phase

Status

Not yet recruiting 2 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Colorectal Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 3 Melanoma 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Nasopharyngeal Carcinoma 1 Mesothelioma 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Insulin-Like Growth Factor I, Resistance To 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 HER2-positive Gastric Cancer 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1

Interventions

Doxorubicin 10 Cyclophosphamide 10 Vinblastine 9 Nivolumab 9 Dacarbazine 8 Brentuximab Vedotin 8 fludarabine phosphate 6 fludarabine 6 Radiotherapy 6 Etoposide 6 Bleomycin 6 pembrolizumab 5 Melphalan 5 Whole-Body Irradiation 4 Vincristine 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 4 Tacrolimus 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Thiotepa 2 Sirolimus 2 Radiation 2 Procarbazine 2 Prednisolone 2 Mechlorethamine 2 Carmustine 2 Bendamustine Hydrochloride 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05502250 2026-03-06

HOVON164HL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡